: Speakers

Speakers

03 - 04 October 2022 | San Diego, USA
+ Digital Day: 05 October 2022 | Online

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for Biomarkers & Immuno US: In-Person 2022

Alekhya Pochiraju
Product Development, Global Operations Manager
Genentech
Alex Cao
Executive Director, Oncology Clinical Biomarker Support
Merck & Co.
Anand Giddabasappa
Head of Global Science and Technology, Comparative Medicine
Pfizer
Andrew Allen
Co-Founder, President and Chief Executive Officer
Gritstone Oncology
Antonio Santidrian
Vice President Research & Development and Translational Oncology
Calidi Biotherapeutics
Arnaud Amzallag
Senior Principal Scientist
Bristol-Myers Squibb
Aude-Helene Capietto
Senior Scientific Researcher, Cancer Immunology Department
Genentech
Bonnie Hammer
Vice President, Biologics Development
Invenra
Catherine Aversa-Fleener
Senior Director, Translational Biology
Xencor
Chih-Liang Chin
Executive Director, Pacific Translational Biomarkers
Merck & Co.
Christie Fanton
Executive Director, Translational Research
Nektar Therapeutics
Chrystal Paulos
Director of Translational Research, Melanoma & Cutaneous Malignancies
Emory University
Dan Passeri
President & CEO
Cue Biopharma
Dave Hoon
Professor, Director
St.John's Cancer Institute
Diana Price
Executive Director, Biosciences
Neuropore Therapeutics
Dimitrios Mathios
Neurosurgery Chief Resident
Johns Hopkins University, School of Medicine
Ewa Carrier
Executive Director, Clinical Development
Fibrogen
Ezinneka Imoh
Senior Manager, Oncology Scientific Communications, Global Medical & Scientific Affairs
Karyopharm Therapeutics Inc.
George Poste
Regents Professor
Arizona State University
Graham Jones
Director of Innovation
Novartis
Hong Lin
Head of Clinical Immunology/Flow Cytometry
Stony Brook University
Hua Eleanor Yu
Billy and Audrey Wilder Endowed Professor
City of Hope Comprehensive Cancer Center
Jadwiga Bienkowska
Sr. Director, Computational Biology ORD
Pfizer
Jean-Marie Bruey
Vice President, Translational Medicine
GossamerBio
Jeffrey Skolnik
Vice President, Clinical Development
Inovio Pharmaceuticals
Jeffrey Wallin
Senior Director, Biomarker Sciences
Gilead
Joanne Tan
Director
Nkarta Therapeutics
John Lu
CSO
HebeCell Corporation
John Rossi
Head of Translational Medicine, SVP Research
Cero Therapeutics
Katherine Call
Former Senior Director
Sanofi
Ken Chang
Director, Clinical Biomarkers
Daiichi Sankyo
Kenneth Ramos
Executive Director
Texas A&M
Kevin Gergich
Executive Director, Oncology Clinical Operations
MSD
Koustubh Ranade
Head of Translational Medicine at Immunocore
Immunocore
Liling Warren
Director, Head of Translational Medicine Statistics
Teva Pharma
Luke Devey
Vice President, Translational Sciences, Immunology
Janssen
Mark Salvati
Global Product General Manager, Amgen Oncology Early Development
Amgen
Matthew Kunicki
Senior Scientist
Pfizer
Michael Groaning
Global Medical Affairs Lead
Amgen
Michael Roehrl
Director, Precision Pathology
Memorial Sloan Kettering Cancer Centre
Michelle Graham
Principal Research Scientist
AbbVie
Mike Damore
Director, Translational Oncology
Pfizer
Mingchao Kang
Group Lead, Head of Technology Platform
Ambrx
Nadia Hassounah
Principal Scientist, Translational Immuno-Oncology
Novartis
Nathalie Fiaschi
Director, Oncology & Angiogenesis
Regeneron
Nicole Bjorklund
Director, Translational Sciences
Cohen Veterans Bioscience
Parris Pope
Head of Medical Affairs
Inmune Bio
Paul Moore
Vice President, Cell Biology and Immunity
Macrogenics
Philip M Arlen
President and CEO
Precision Biologics, Inc
Pravin Kaumaya
Professor and Director Vaccine Development
The Ohio State University
Russell LaMontagne
President and CEO
Boston Immune Technologies & Therapeutics
Sean Xie
Director, Drug Safety Research & Development
Pfizer
Simi Ahmed
Senior Vice President, Strategic Partnerships
NYSCF
Simone Filosto
Director, Cell Biology, Translational Medicine
Kite Pharma
Sonia Iyer
Associate Director Translational Immuno-Oncology, Oncology R&D
AstraZeneca
Tauseef R. Butt
President and Chief Executive Officer
Progenra
Youg Thaker
Senior Scientist
Sorrento Therapeutics

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.